These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31895778)

  • 1. The serum interleukin-26 level is a potential biomarker for chronical hepatitis B.
    Luo L; Jiang L; Tian Z; Zhang X
    Medicine (Baltimore); 2020 Jan; 99(1):e18462. PubMed ID: 31895778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X; Li J; Liu J; Gao M; Zhou L; Lu W
    Medicine (Baltimore); 2017 Jun; 96(23):e7064. PubMed ID: 28591041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
    Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
    J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.
    Wang HJ; Jiang YF; Wang XR; Zhang ML; Gao PJ
    World J Gastroenterol; 2016 May; 22(18):4529-37. PubMed ID: 27182162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
    Ma SW; Huang X; Li YY; Tang LB; Sun XF; Jiang XT; Zhang YX; Sun J; Liu ZH; Abbott WG; Dong YH; Naoumov NV; Hou JL
    J Hepatol; 2012 Apr; 56(4):775-81. PubMed ID: 22173154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Th17 cytokines during telbivudine therapy in patients with chronic hepatitis B.
    Hao C; Wang J; Kang W; Xie Y; Zhou Y; Ma L; Peng M; Bai X; Lian J; Jia Z
    Viral Immunol; 2013 Oct; 26(5):336-42. PubMed ID: 24028690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-35 modulates the balance between viral specific CD4
    Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
    Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.
    Su ZJ; Yu XP; Guo RY; Ming DS; Huang LY; Su ML; Deng Y; Lin ZZ
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):437-44. PubMed ID: 23747030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B.
    Zhang F; Yao S; Yuan J; Zhang M; He Q; Yang G; Gao Z; Liu H; Chen X; Zhou B
    Virol J; 2011 Jun; 8():270. PubMed ID: 21639870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic changes of Th1/Th2 type cytokines in peripheral blood of patients with hepatitis B e antigen-positive chronic hepatitis B treated with telbivudine].
    Zhang L; Zhang DZ; Chen M; He H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):175-9. PubMed ID: 19335978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.
    Feng J; Lu L; Hua C; Qin L; Zhao P; Wang J; Wang Y; Li W; Shi X; Jiang Y
    PLoS One; 2011; 6(7):e21698. PubMed ID: 21750724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B.
    Jiang X; Zhang M; Lai Q; Huang X; Li Y; Sun J; Abbott WG; Ma S; Hou J
    PLoS One; 2011; 6(12):e28871. PubMed ID: 22194934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.